A Phase II Study of ZD1839 and Tamoxifen in Patients With Epithelial Ovarian Carcinoma, Cancer of the Fallopian Tube or the Peritoneum Refractory to Platinum- and Taxane-based Therapy.
Phase of Trial: Phase II
Latest Information Update: 05 Aug 2010
At a glance
- Drugs Gefitinib (Primary) ; Tamoxifen (Primary)
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Adverse reactions; Therapeutic Use
- 05 Aug 2010 New trial record